Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma

Authors: Colson, Philippe; Borentain, Patrick1; Coso, Diane2; Chabannon, Christian2; Tamalet, Catherine; Gérolami, René1

Source: British Journal of Haematology, Volume 143, Number 1, October 2008 , pp. 148-150(3)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Keywords: hepatitis B virus; reactivation; lymphoma; chemotherapy; haematopoietic stem cell transplantation; entecavir

Document Type: Correspondence

DOI: http://dx.doi.org/10.1111/j.1365-2141.2008.07318.x

Affiliations: 1: Service d'Hépato-Gastro-Entérologie, Centre Hospitalier Universitaire Conception, Marseille Cedex 05 2: Service d'Onco-hématologie, Institut Paoli Calmettes, Marseille, France., Email: rene.gerolami@ap-hm.fr

Publication date: 2008-10-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page